Loading...
Short‐term changes in left and right systolic function following ferric carboxymaltose: a substudy of the Myocardial‐IRON trial
AIMS: The mechanisms underlying the beneficial effect of ferric carboxymaltose (FCM) in patients with heart failure (HF) and iron deficiency (ID) have not been completely characterized. The Myocardial‐IRON trial was a double‐blind, randomized trial that evaluated myocardial iron repletion following...
Na minha lista:
| Udgivet i: | ESC Heart Fail |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7754736/ https://ncbi.nlm.nih.gov/pubmed/33040491 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13053 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|